{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:27:46Z","timestamp":1740108466173,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00296-020-04695-1","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T16:03:43Z","timestamp":1599062623000},"page":"2047-2055","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4438-2779","authenticated-orcid":false,"given":"Hafis","family":"Muhammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2014-3925","authenticated-orcid":false,"given":"R.","family":"Naveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3760-2198","authenticated-orcid":false,"given":"Rajat","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5313-7316","authenticated-orcid":false,"given":"Harikrishnan","family":"Gangadharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7396","authenticated-orcid":false,"given":"Durga P.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9230-4137","authenticated-orcid":false,"given":"James B.","family":"Lilleker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6492-1288","authenticated-orcid":false,"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,2]]},"reference":[{"key":"4695_CR1","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292:344\u2013347. https:\/\/doi.org\/10.1056\/NEJM197502132920706","journal-title":"N Engl J Med"},{"key":"4695_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/1759720X16655126","volume":"8","author":"J Lilleker","year":"2016","unstructured":"Lilleker J, Murphy S, Cooper R (2016) Selected aspects of the current management of myositis. Ther Adv Musculoskelet Dis 8:136\u2013144. https:\/\/doi.org\/10.1177\/1759720X16655126","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"4695_CR3","doi-asserted-by":"publisher","first-page":"101486","DOI":"10.1016\/j.berh.2020.101486","volume":"34","author":"H Chinoy","year":"2020","unstructured":"Chinoy H, Lilleker JB (2020) Pitfalls in the diagnosis of myositis. Best Pract Res Clin Rheumatol 34:101486. https:\/\/doi.org\/10.1016\/j.berh.2020.101486","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4695_CR4","unstructured":"de Souza FH, Behrens Pinto GL, de Souza JM, Olivo Pallo PA, Hoff LS, Shinjo SK. Sporadic inclusion body myositis in the rheumatology clinic. Indian J Rheumatol. [Epub ahead of print] [cited 2020 Aug 22]. Available from: https:\/\/www.indianjrheumatol.com\/preprintarticle.asp?id=289182"},{"key":"4695_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s00296-019-04439-w","volume":"39","author":"TG Sundaram","year":"2019","unstructured":"Sundaram TG, Aggarwal A, Ganguly S et al (2019) Microsporidial myositis in adult-onset immunodeficiency: case-based review. Rheumatol Int 39:1995\u20132003. https:\/\/doi.org\/10.1007\/s00296-019-04439-w","journal-title":"Rheumatol Int"},{"key":"4695_CR6","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/CPM.0000000000000171","volume":"23","author":"LJ Witt","year":"2016","unstructured":"Witt LJ, Curran JJ, Strek ME (2016) The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med 23:218\u2013226. https:\/\/doi.org\/10.1097\/CPM.0000000000000171","journal-title":"Clin Pulm Med"},{"key":"4695_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1136\/annrheumdis-2012-201800","volume":"73","author":"R Aggarwal","year":"2014","unstructured":"Aggarwal R, Cassidy E, Fertig N et al (2014) Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients. Ann Rheum Dis 73:227\u2013232. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201800","journal-title":"Ann Rheum Dis"},{"key":"4695_CR8","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","volume":"30","author":"AL Mammen","year":"2020","unstructured":"Mammen AL, Allenbach Y, Stenzel W et al (2020) 239th ENMC International Workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 December 2018. Neuromuscul Disord NMD 30:70\u201392. https:\/\/doi.org\/10.1016\/j.nmd.2019.10.005","journal-title":"Neuromuscul Disord NMD"},{"key":"4695_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/03009740802687455","volume":"38","author":"K Fujikawa","year":"2009","unstructured":"Fujikawa K, Kawakami A, Kaji K et al (2009) Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155\/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol 38:263\u2013267. https:\/\/doi.org\/10.1080\/03009740802687455","journal-title":"Scand J Rheumatol"},{"key":"4695_CR10","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00296-019-04398-2","volume":"39","author":"K Huang","year":"2019","unstructured":"Huang K, Vinik O, Shojania K et al (2019) Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review. Rheumatol Int 39:1971\u20131981. https:\/\/doi.org\/10.1007\/s00296-019-04398-2","journal-title":"Rheumatol Int"},{"key":"4695_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","volume":"77","author":"GC Dobloug","year":"2018","unstructured":"Dobloug GC, Svensson J, Lundberg IE, Holmqvist M (2018) Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study. Ann Rheum Dis 77:40\u201347. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211402","journal-title":"Ann Rheum Dis"},{"key":"4695_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001214","author":"H Muhammed","year":"2019","unstructured":"Muhammed H, Gupta L, Zanwar AA et al (2019) Infections are leading cause of in-hospital mortality in Indian patients with inflammatory myopathy. JCR J Clin Rheumatol. https:\/\/doi.org\/10.1097\/RHU.0000000000001214","journal-title":"JCR J Clin Rheumatol"},{"key":"4695_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4103\/2229-3485.148816","volume":"6","author":"SK Gupta","year":"2015","unstructured":"Gupta SK, Nayak RP, Shivaranjani R, Vidyarthi SK (2015) A questionnaire study on the knowledge, attitude, and the practice of pharmacovigilance among the healthcare professionals in a teaching hospital in South India. Perspect Clin Res 6:45\u201352. https:\/\/doi.org\/10.4103\/2229-3485.148816","journal-title":"Perspect Clin Res"},{"key":"4695_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.15171\/jcs.2015.017","volume":"4","author":"V Zamanzadeh","year":"2015","unstructured":"Zamanzadeh V, Ghahramanian A, Rassouli M et al (2015) Design and implementation content validity study: development of an instrument for measuring patient-centered communication. J Caring Sci 4:165\u2013178. https:\/\/doi.org\/10.15171\/jcs.2015.017","journal-title":"J Caring Sci"},{"key":"4695_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/injr.injr_40_19","volume":"14","author":"L Gupta","year":"2019","unstructured":"Gupta L, Appani S, Janardana R et al (2019) Meeting report: MyoIN\u2014Pan-India collaborative network for myositis research. Indian J Rheumatol 14:136. https:\/\/doi.org\/10.4103\/injr.injr_40_19","journal-title":"Indian J Rheumatol"},{"key":"4695_CR16","unstructured":"ICMR Ethical Guidelines. 2020. https:\/\/ethics.ncdirindia.org\/ICMR_Ethical_Guidelines.aspx. Accessed 12 Aug 2020"},{"key":"4695_CR17","unstructured":"Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). 2020. The EQUATOR Network. https:\/\/www.equator-network.org\/reporting-guidelines\/improving-the-quality-of-web-surveys-the-checklist-for-reporting-results-of-internet-e-surveys-cherries\/. Accessed 7 Aug 2020"},{"key":"4695_CR18","unstructured":"A Delphi study to build consensus on the definition and use of big data in obesity research. Int J Obes. 2020. https:\/\/www.nature.com\/articles\/s41366-018-0313-9. Accessed 29 Jun 2020"},{"key":"4695_CR19","unstructured":"Prognostic Significance of Bicaudal D2 Antibodies in Sistemic Sclerosis (SSc) Patients. In: ACR Meet. Abstr. 2020. https:\/\/acrabstracts.org\/abstract\/prognostic-significance-of-bicaudal-d2-antibodies-in-sistemic-sclerosis-ssc-patients\/. Accessed 29 Jun 2020"},{"key":"4695_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3899\/jrheum.160871","volume":"44","author":"SL Tansley","year":"2017","unstructured":"Tansley SL, Betteridge ZE, Simou S et al (2017) Anti-HMGCR Autoantibodies in juvenile idiopathic inflammatory myopathies identify a rare but clinically important subset of patients. J Rheumatol 44:488\u2013492. https:\/\/doi.org\/10.3899\/jrheum.160871","journal-title":"J Rheumatol"},{"key":"4695_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3346\/jkms.2016.31.7.1013","volume":"31","author":"DP Misra","year":"2016","unstructured":"Misra DP, Agarwal V, Negi VS (2016) Rheumatology in india: a bird\u2019s eye view on organization, epidemiology, training programs and publications. J Korean Med Sci 31:1013. https:\/\/doi.org\/10.3346\/jkms.2016.31.7.1013","journal-title":"J Korean Med Sci"},{"key":"4695_CR22","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s00415-014-7313-z","volume":"261","author":"J van de Vlekkert","year":"2014","unstructured":"van de Vlekkert J, Hoogendijk JE, de Visser M (2014) Long-term follow-up of 62 patients with myositis. J Neurol 261:992\u2013998. https:\/\/doi.org\/10.1007\/s00415-014-7313-z","journal-title":"J Neurol"},{"key":"4695_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.autrev.2006.08.009","volume":"6","author":"LG Rider","year":"2007","unstructured":"Rider LG (2007) The heterogeneity of juvenile myositis. Autoimmun Rev 6:241\u2013247. https:\/\/doi.org\/10.1016\/j.autrev.2006.08.009","journal-title":"Autoimmun Rev"},{"key":"4695_CR24","first-page":"880","volume":"34","author":"S Tansley","year":"2016","unstructured":"Tansley S, Shaddick G, Christopher-Stine L et al (2016) Developing standardised treatment for adults with myositis and different phenotypes: an international survey of current prescribing preferences. Clin Exp Rheumatol 34:880\u2013884","journal-title":"Clin Exp Rheumatol"},{"key":"4695_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"F Bellutti Enders","year":"2017","unstructured":"Bellutti Enders F, Bader-Meunier B, Baildam E et al (2017) Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis 76:329\u2013340. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209247","journal-title":"Ann Rheum Dis"},{"key":"4695_CR26","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.39753","volume":"68","author":"CT Deakin","year":"2016","unstructured":"Deakin CT, Yasin SA, Simou S et al (2016) Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis. Arthritis Rheumatol Hoboken NJ 68:2806\u20132816. https:\/\/doi.org\/10.1002\/art.39753","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"4695_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R et al (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314\u2013324. https:\/\/doi.org\/10.1002\/art.37754","journal-title":"Arthritis Rheum"},{"key":"4695_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00296-019-04467-6","volume":"40","author":"T Khoo","year":"2020","unstructured":"Khoo T, Limaye V (2020) Biologic therapy in the idiopathic inflammatory myopathies. Rheumatol Int 40:191\u2013205. https:\/\/doi.org\/10.1007\/s00296-019-04467-6","journal-title":"Rheumatol Int"},{"issue":"Suppl 11","key":"4695_CR29","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM et al (2011) Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient\/parent global activity, manual muscle testing (MMT), health assessment questionnaire (HAQ)\/childhood health assessment questionnaire (C-HAQ), childhood myositis assessment scale (CMAS), myositis disease activity assessment tool (MDAAT), disease activity score (DAS), short form 36 (SF-36), child health questionnaire (CHQ), physician global damage, myositis damage index (MDI), quantitative muscle testing (QMT), myositis functional index-2 (FI-2), myositis activities profile (MAP), inclusion body myositis functional rating scale (IBMFRS), cutaneous dermatomyositis disease area and severity index (CDASI), cutaneous assessment tool (CAT), dermatomyositis skin severity index (DSSI), skindex, and dermatology life quality index (DLQI). Arthritis Care Res 63(Suppl 11):S118\u2013157. https:\/\/doi.org\/10.1002\/acr.20532","journal-title":"Arthritis Care Res"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04695-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04695-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04695-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T23:49:07Z","timestamp":1630540147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04695-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,2]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4695"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04695-1","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2020,9,2]]},"assertion":[{"value":"6 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"LG declares that she has no conflicts on interest in relation to the manuscript, including no relationship with pharmaceutical companies. HM declares that he has no conflicts on interest in relation to the manuscript, including no relationship with pharmaceutical companies. NR declares that he has no conflicts on interest in relation to the manuscript, including no relationship with pharmaceutical companies. RK declares that she has no conflicts on interest in relation to the manuscript, including no relationship with pharmaceutical companies. HG declares that he has no conflicts on interest in relation to the manuscript, including no relationship with pharmaceutical companies. DPM declares that he has no conflicts on interest in relation to the manuscript, including no relationship with pharmaceutical companies. JBL declares that he has no conflicts on interest in relation to the manuscript. HC declares that he has no conflicts on interest in relation to the manuscript. VA declares that he has no conflicts on interest in relation to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved as exempt from review by the Institute Ethics Committee, SGPGIMS, Lucknow (document submission number 2020-109-IP-EXP-16 on 07 April, 2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was taken at the beginning the survey.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}